{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:32:16Z","timestamp":1781757136534,"version":"3.54.5"},"reference-count":44,"publisher":"Microbiology Society","issue":"9","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,9]]},"abstract":"<jats:p>Invasive disease caused by <jats:italic>\n                     <jats:named-content content-type=\"species\">\n                        <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/doi.org\/10.1601\/nm.5677\" xlink:type=\"simple\">Streptococcus pneumoniae<\/jats:ext-link>\n                     <\/jats:named-content>\n                  <\/jats:italic> (IPD) is one of the leading causes of morbidity and mortality in young children worldwide. In Argentina, PCV13 was introduced into the childhood immunization programme nationwide in 2012 and PCV7 was available from 2000, but only in the private market. Since 1993 the National IPD Surveillance Programme, consisting of 150 hospitals, has conducted nationwide pneumococcal surveillance in Argentina in children under 6\u2009years of age, as part of the SIREVA II-OPS network. A total of 1713 pneumococcal isolates characterized by serotype (Quellung) and antimicrobial resistance (agar dilution) to ten antibiotics, belonging to three study periods: pre-PCV7 era 1998\u20131999 (pre-PCV), before the introduction of PCV13 2010\u20132011 (PCV7) and after the introduction of PCV13 2012\u20132013 (PCV13), were available for inclusion. Fifty-four serotypes were identified in the entire collection and serotypes 14, 5 and 1 represented 50\u200a% of the isolates. Resistance to penicillin was 34.9\u200a%, cefotaxime 10.6\u200a%, meropenem 4.9\u200a%, cotrimoxazole 45\u200a%, erythromycin 21.5\u200a%, tetracycline 15.4\u200a% and chloramphenicol 0.4\u200a%. All the isolates were susceptible to levofloxacin, rifampin and vancomycin. Of 1713 isolates, 1061 (61.9\u200a%) were non-susceptible to at least one antibiotic and 235(13.7\u200a%) were multidrug resistant. A subset of 413 isolates was randomly selected and whole-genome sequenced as part of Global Pneumococcal Sequencing Project (GPS). The genome data was used to investigate the population structure of <jats:italic>\n                     <jats:named-content content-type=\"species\">\n                        <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/doi.org\/10.1601\/nm.5677\" xlink:type=\"simple\">S. pneumoniae<\/jats:ext-link>\n                     <\/jats:named-content>\n                  <\/jats:italic> defining pneumococcal lineages using Global Pneumococcal Sequence Clusters (GPSCs), sequence types (STs) and clonal complexes (CCs), prevalent serotypes and their associated pneumococcal lineages and genomic inference of antimicrobial resistance. The collection showed a great diversity of strains. Among the 413 isolates, 73 known and 36 new STs were identified belonging to 38 CCs and 25 singletons, grouped into 52 GPSCs. Important changes were observed among vaccine types when pre-PCV and PCV13 periods were compared; a significant decrease in serotypes 14, 6B and 19F and a significant increase in 7F and 3. Among non-PCV13 types, serogroup 24 increased from 0\u200a% in pre-PCV to 3.2\u200a% in the PCV13 period. Our analysis showed that 66.1\u200a% (273\/413) of the isolates were predicted to be non-susceptible to at least one antibiotic and 11.9\u200a% (49\/413) were multidrug resistant. We found an agreement of 100\u200a% when comparing the serotype determined by Quellung and WGS-based serotyping and 98.4\u200a% of agreement in antimicrobial resistance. Continued surveillance of the pneumococcal population is needed to reveal the dynamics of pneumococcal isolates in Argentina in post-PCV13. This article contains data hosted by Microreact.<\/jats:p>","DOI":"10.1099\/mgen.0.000636","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T13:36:21Z","timestamp":1632922581000},"source":"Crossref","is-referenced-by-count":24,"title":["Population genetic structure, serotype distribution and antibiotic resistance of Streptococcus pneumoniae causing invasive disease in children in Argentina"],"prefix":"10.1099","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1551-7208","authenticated-orcid":false,"given":"Paula","family":"Gagetti","sequence":"first","affiliation":[{"name":"Antimicrobial Agents Division. National Reference Laboratory in Antimicrobial Resistance. INEI-ANLIS \u201cDr. Carlos G. Malbr\u00e1n\u201d, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie W.","family":"Lo","sequence":"additional","affiliation":[{"name":"Parasites and Microbes, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5096-392X","authenticated-orcid":false,"given":"Paulina A.","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, USA"},{"name":"Rollins School of Public Health, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Gladstone","sequence":"additional","affiliation":[{"name":"Parasites and Microbes, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-3542","authenticated-orcid":false,"given":"Mabel","family":"Regueira","sequence":"additional","affiliation":[{"name":"Bacteriology Division. INEI-ANLIS \u201cDr. Carlos G. Malbr\u00e1n\u201d, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Faccone","sequence":"additional","affiliation":[{"name":"Antimicrobial Agents Division. National Reference Laboratory in Antimicrobial Resistance. INEI-ANLIS \u201cDr. Carlos G. Malbr\u00e1n\u201d, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SIREVA-Argentina group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith P.","family":"Klugman","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Breiman","sequence":"additional","affiliation":[{"name":"Emory Global Health Institute, Atlanta, USA"},{"name":"Rollins School of Public Health, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"McGee","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Bentley","sequence":"additional","affiliation":[{"name":"Parasites and Microbes, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-6746","authenticated-orcid":false,"given":"Alejandra","family":"Corso","sequence":"additional","affiliation":[{"name":"Antimicrobial Agents Division. National Reference Laboratory in Antimicrobial Resistance. INEI-ANLIS \u201cDr. Carlos G. Malbr\u00e1n\u201d, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","volume-title":"The Burden of Pneumococcal Disease and Cost-Effectiveness of a Pneumococcal Vaccine in Latin America and the Caribbean. A Review of the Evidence and a Preliminary Economic Analysis","author":"Constenla","year":"2007"},{"key":"R2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal capsules and their types: past, present and future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"R3","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"R4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2019","journal-title":"Lancet"},{"key":"R5","article-title":"WHO vaccine-preventable diseases: monitoring system. 2018 global summary Coverage time series for Argentina","year":"2018"},{"key":"R6","article-title":"SIREVA II","year":"2014"},{"key":"R7","volume-title":"M100S 29th Edition: Performance Standards for Antimicrobial Susceptibility Testing","year":"2019"},{"key":"R8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ebiom.2019.04.021","article-title":"International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact","volume":"43","author":"Gladstone","year":"2019","journal-title":"EBioMedicine"},{"key":"R10","article-title":"SeroBA: rapid high-throughput serotyping of Streptococcus pneumoniae from whole genome sequence data","volume":"4","author":"Epping","year":"2018","journal-title":"Microb Genom"},{"key":"R11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.21105\/joss.00118","article-title":"Multilocus sequence typing by blast from de novo assemblies against PubMLST","volume":"8","author":"Page","year":"2016","journal-title":"J Open Source Softw"},{"key":"R12","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00756-16","article-title":"Penicillin-binding protein transpeptidase signatures for tracking and predicting \u03b2-lactam resistance levels in Streptococcus pneumoniae","volume":"7","author":"Li","year":"2016","journal-title":"mBio"},{"key":"R13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1186\/s12864-017-4017-7","article-title":"Validation of \u03b2-lactam minimum inhibitory concentration predictions for pneumococcal isolates with newly encountered penicillin binding protein (PBP) sequences","volume":"18","author":"Li","year":"2017","journal-title":"BMC Genomics"},{"key":"R14","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cmi.2016.08.001","article-title":"Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States","volume":"22","author":"Metcalf","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cmi.2015.08.027","article-title":"Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA","volume":"22","author":"Metcalf","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R16","article-title":"ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads","volume":"3","author":"Hunt","year":"2017","journal-title":"Microb Genom"},{"key":"R17","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/JB.186.5.1518-1530.2004","article-title":"eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data","volume":"186","author":"Feil","year":"2004","journal-title":"J Bacteriol"},{"key":"R18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1101\/gr.241455.118","article-title":"Fast and flexible bacterial genomic epidemiology with PopPUNK","volume":"29","author":"Lees","year":"2019","journal-title":"Genome Res"},{"key":"R19","doi-asserted-by":"crossref","first-page":"8877","DOI":"10.1016\/j.vaccine.2011.09.075","article-title":"Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination","volume":"29","author":"Hanage","year":"2011","journal-title":"Vaccine"},{"key":"R20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/infdis\/jix472","article-title":"Comparative genomic analysis and in vivo modeling of Streptococcus pneumoniae ST3081 and ST618 isolates reveal key genetic and phenotypic differences contributing to clonal replacement of serotype 1 in The Gambia","volume":"216","author":"Bricio-Moreno","year":"2017","journal-title":"J Infect Dis"},{"key":"R21","first-page":"29","article-title":"Prevalence of mef and ermB genes in invasive pediatric erythromycin-resistant Streptococcus pneumoniae isolates from Argentina","volume":"41","author":"Corso","year":"2009","journal-title":"Rev Argent Microbiol"},{"key":"R22","first-page":"262","article-title":"Macrolide resistance in Streptococcus pneumoniae isolated from Argentinian pediatric patients suffering from acute otitis media","volume":"45","author":"Reijtman","year":"2013","journal-title":"Rev Argent Microbiol"},{"key":"R23","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1016\/j.vaccine.2017.07.030","article-title":"Characterization of Streptococcus pneumoniae invasive serotype 19A isolates from Argentina (1993\u20132014","volume":"16","author":"Gagetti","year":"2017","journal-title":"Vaccine"},{"key":"R24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1473-3099(19)30297-X","article-title":"Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study","volume":"19","author":"Lo","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R25","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1016\/j.vaccine.2017.07.010","article-title":"Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure","volume":"35","author":"Camilli","year":"2017","journal-title":"Vaccine"},{"key":"R26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"R28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007438","article-title":"Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci","volume":"14","author":"Azarian","year":"2018","journal-title":"PLoS Pathog"},{"key":"R29","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.3389\/fmicb.2018.02670","article-title":"A population-based descriptive atlas of invasive pneumococcal strains recovered within the U.S. during 2015-2016","volume":"19","author":"Beall","year":"2018","journal-title":"Front Microbiol"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01011-09"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000357"},{"key":"R32","article-title":"Emergence of multidrug resistant serotype 24 among children under 2 years old with invasive pneumococcal disease after the introduction of PCV13 in Argentina. (p1429) Idweek 2018, San Francisco, CA, USA, 3-7 October 2018","author":"Gagetti","year":"2018"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41983-8"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30349-9"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.3201\/eid2411.180326"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002508"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2017.10.026"},{"key":"R38","article-title":"The impact of serotype-specific distribution of Streptococcus pneumoniae in the clonal complex 230 after the subsidised PCV13 vaccine in a national immunization programme in Catalonia, Spain. (P0355) 29th ECCMID, the European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Netherlands, 13\u201316 April 2019","author":"Esteva","year":"2019"},{"key":"R39","first-page":"1361","article-title":"Persistent circulation of vaccine serotypes and serotype replacement after 5 years of infant immunization with 13-valent Pneumococcal Conjugate Vaccine in the United Kingdom","volume":"221","author":"Kandasamy","year":"2020","journal-title":"J Infect Dis"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.085"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36799-x"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.06.004"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000832"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151125"}],"container-title":["Microbial Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/mgen\/10.1099\/mgen.0.000636?crawler=true&mimetype=application\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T23:29:57Z","timestamp":1702596597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/mgen\/10.1099\/mgen.0.000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,9]]}},"URL":"https:\/\/doi.org\/10.1099\/mgen.0.000636","relation":{},"ISSN":["2057-5858"],"issn-type":[{"value":"2057-5858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]}}}